We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
Betaferon® Treatment Delays Disability In Early MS; Strong Efficacy Not Affected By Neutralizing Antibodies
Multiple Sclerosis Betaferon® (interferon beta-1b) significantly delays the development of confirmed disability progression and the development of clinically definite multiple sclerosis (MS) in patients who are treated shortly after their first clinical MS event or "attack". The presence of neutralizing antibodies (NAbs) does not affect the efficacy of early Betaferon® treatment. [click link for full article]
Custom Search
